Protein Expression in the Field of Proteomics
Proteomics has been a major focus as researchers attempt to understand the vast amount of genomic data. Protein expression studies have majorly contributed to understanding the complexity of gene study and regulation, along with post-translational modifications. Typical results of proteomics studies understand the inventories of the protein content of a sample or lists of differentially expressed proteins across multiple conditions, such as diseased patients, controls, etc. Protein expression studies between the proteome and subproteome of two individuals can be compared to identify novel proteins in signal transduction pathways, or the identification of disease-specific proteins. With the advent of technology, like mass spectrometry and protein microarray, it is now becoming easy to perform protein expression studies. It has shown great potential to increase the throughput of proteomic research. Expression profiling has contributed to proteomics by providing wide applications in protein-protein interaction studies. Thus, proteomics (which has contributed in the field of drug discovery, drug target prediction, and structural protein prediction) have a wide range of applications in protein expression studies. They have also contributed to its high demand. Hence this factor is driving the protein expression market.
The other factors, such as the rise in the R&D activity in the pharma sector, advancements in the biologics market, and increasing incidences of chronic diseases are driving the protein expression market.
Market on Verge of Saturation
The protein expression market has various applications in the field of biotechnology. The major players have already penetrated all these application segments. The market in the developed regions is on the verge of saturation. There is no proper room for new players to establish a footprint in the market. Though emerging markets hold promise, it is near to impossible to overtake the domination due to the advanced technology at bay for the global market leaders. New technology is currently at a bare minimum. Market will be fruitful for those who come up with innovative products and offer replacements for the already existing practices. The saturation of the market is hindering the growth of protein expression market.
North America Dominates the Market
North America accounted for the largest market value of USD 499.14 million in 2017 and is expected to witness a CAGR of 5.8% during the forecast period of 2018-2023. The Asia-Pacific market is expected to have a comparatively higher CAGR during the forecast period. Increasing investments in R&D, growing outsourced production, and R&D units in India and China (due to cost-effective production), are propelling the growth of the market in Asia-Pacific.
Key Developments in the Market
- August 2017: Thermo Fisher Scientific acquired the Patheon.
- July 2017: Agilent Technologies acquired the Raman Spectroscopy Innovator, Cobalt Light Systems.
Reasons to Purchase the Report
- Follow the current and future protein expression market in the developed and emerging markets.
- Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
- Identify the segment that is expected to dominate the market.
- Identify the regions that are expected to witness the fastest growth during the forecast period.
- Identify the latest developments, market shares, and strategies employed by the major market players.
- 3-month analyst support along with the Market Estimate sheet (in Excel).
This report can be customized to meet your requirements.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1.1 Rise in the R&D Activity in the Pharma Sector
6.1.2 Protein Expression in the Field of Proteomics
6.1.3 Advancements in the Biologics Market
6.1.4 Increasing Incidences of Chronic Diseases
6.2.1 Market on the Verge of Saturation
6.4 Key Challenges
7. Market Segmentation
7.1 By Expression Systems
7.1.1 Cell-free Expression
7.1.2 Bacterial Expression
7.1.3 Yeast Expression
7.1.4 Algal Expression
7.1.5 Insect Expression
7.1.6 Mammalian Expression
7.2 By Products
7.3 By End User
7.4 By Geography
7.4.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 Australia & New Zealand
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
7.4.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of the Middle East & Africa
7.4.5 South America
220.127.116.11 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Agilent Technologies, Inc.
9.2 Bio-Rad Technologies
9.3 EMD Millipore
9.4 New England Biolabs, Inc.
9.5 Oxford Expression Technologies, Ltd.
9.6 Promega Corporation
9.7 Qiagen N.V.
9.8 Sigma-Aldrich Corporation
9.9 Takara Bio, Inc.
9.10 Thermo Fisher Scientific, Inc.
*List not Exhaustive
10. Future of the Market
- Agilent Technologies Inc.
- Bio-Rad Technologies
- EMD Millipore
- New England Biolabs Inc.
- Oxford Expression Technologies LTD
- Promega Corporation
- Qiagen N.V.
- Sigma-Aldrich Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.